23874 Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices 

relationships that provide young people, 

who have an incarcerated parent with 

caring adult volunteers. 

Additional information about this 

program and its purpose can be located 

on the following Web site: http:// 

www.acf.hhs.gov/programs/fysb. 

Contact for Further Information: 

Gloria Watkins, Family Youth and 

Services Bureau, 1250 Maryland Ave., 

SW., Washington, DC 20047. Telephone: 

(202) 205–9546. E-mail: 

Gloria.Watkins@acf.hhs.gov. 

Dated: May 12, 2009. 

Maiso L. Bryant, 

Acting Commissioner, Administration on 

Children, Youth and Families. 

[FR Doc. E9–11816 Filed 5–20–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0210] 

Temporary Deferment of Activities 

Relating to Medical Device 

Submissions 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that the Center for Devices and 

Radiological Health (CDRH) will be 

moving from various Rockville, 

Maryland locations to Building 66 at 

10903 New Hampshire Avenue in Silver 

Spring, Maryland from approximately 

mid May 2009 until the beginning of 

August 2009. Offices will progressively 

move over weekends during this period. 

Specifically, moves will occur on 

Friday, Saturday, and Sunday except on 

holiday weekends. During the period 

required for relocation of files, 

equipment, and agency personnel, the 

Center for Devices and Radiological 

Health will not officially receive 

premarket submissions on the Friday of 

a move weekend and the Monday after 

a move weekend. 

FOR FURTHER INFORMATION CONTACT: 

Marjorie Shulman, Center for Devices 

and Radiological Health (HFZ–404), 

Food and Drug Administration, 9200 

Corporate Blvd., Rockville, MD 20850, 

240–276–4186 or 

Marjorie.shulman@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

CDRH is responsible for activities 

under sections 510, 513, 515, and 520 of 

the Federal Food, Drug, and Cosmetic 

Act (the act) (21 U.S.C. 360, 360c, 360e, 

and 360j). These activities include, but 

are not limited to: 

1. Advising the Director, CDRH, and 

other FDA officials on all medical 

device submissions, such as premarket 

notification submissions under section 

510(k) of the act, device classifications 

under section 513 of the act, premarket 

approval applications (PMA’s) and 

product development protocols (PDP’s) 

under section 515 of the act, and 

clinical investigations under section 520 

of the act; 

2. Determining substantial 

equivalence for premarket notification 

submissions; 

3. Planning, conducting, and 

coordinating CDRH actions regarding 

PMA’s, PDP’s, and investigational 

device exemption approvals, denials, or 

withdrawals of approval; 

4. Monitoring sponsors’ compliance 

with regulatory requirements; and 

5. Conducting a continuing review, 

surveillance, and medical evaluation of 

the labeling, clinical experience, and 

required reports submitted by sponsors 

holding approved applications. 

In an effort to consolidate CDRH 

offices, FDA is moving various CDRH 

offices from their present Rockville, 

Maryland locations to Building 66 at 

10903 New Hampshire Avenue in Silver 

Spring, Maryland. Offices will 

progressively move, during weekends, 

during this period. Specifically, moves 

will occur on Friday, Saturday, and 

Sunday except on holiday weekends. 

During the period required for 

relocation of files, equipment, and 

agency personnel, the agency, 

specifically the Center for Devices and 

Radiological Health, will not officially 

receive submissions on the Friday of a 

move weekend and the Monday after a 

move weekend. Although mail will be 

delivered to a CDRH address during the 

move, CDRH will not be able to receive 

it on Fridays and Mondays, and will 

have limited capacity on Tuesday. 

Accordingly, mail delivered on Friday 

or Monday will be logged in on a 

staggered basis to preserve equity in the 

order of receipt and manageability of the 

accumulated workload. Specifically, 

mail delivered on Friday or Monday 

will be received on Tuesday and mail 

delivered on Tuesday will be received 

by Wednesday. Mail delivered on 

Wednesdays and Thursdays will remain 

unaffected. 

The new mailing address for 

submissions and updated telephone 

contact information may be found by 

accessing www.fda.gov/cdrh/ 

whiteoakmove. 

II. Comments 

Persons who may be affected by this 

temporary deferment should contact 

FDA with any questions they may have 

regarding CDRH’s move to the White 

Oak, Maryland. These persons should 

call CDRH’s Division of Small 

Manufacturers, International, and 

Consumer Assistance at 800–638–2041 

(in Maryland, 240–276–3150). 

Dated: May 13, 2009. 

Daniel G. Schultz, 

Director, Center for Devices and Radiological 

Health. 

[FR Doc. E9–11840 Filed 5–20–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Accreditation and Approval of Intertek 

USA, Inc., as a Commercial Gauger 

and Laboratory 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: Notice of accreditation and 

approval of Intertek USA, Inc., as a 

commercial gauger and laboratory. 

SUMMARY: Notice is hereby given that, 

pursuant to 19 CFR 151.12 and 19 CFR 

151.13, Intertek USA, Inc., 101 20th 

Street South, Texas City, TX 77590, has 

been approved to gauge and accredited 

to test petroleum and petroleum 

products, organic chemicals and 

vegetable oils for customs purposes, in 

accordance with the provisions of 19 

CFR 151.12 and 19 CFR 151.13. Anyone 

wishing to employ this entity to conduct 

laboratory analyses and gauger services 

should request and receive written 

assurances from the entity that it is 

accredited or approved by the U.S. 

Customs and Border Protection to 

conduct the specific test or gauger 

service requested. Alternatively, 

inquires regarding the specific test or 

gauger service this entity is accredited 

or approved to perform may be directed 

to the U.S. Customs and Border 

Protection by calling (202) 344–1060. 

The inquiry may also be sent to 

cbp.labhq@dhs.gov. Please reference the 

Web site listed below for a complete 

listing of CBP approved gaugers and 

accredited laboratories.http://cbp.gov/ 

xp/cgov/import/operations_support/ 

labs_scientific_svcs/ 

commercial_gaugers/. 

DATES: The accreditation and approval 

of Intertek USA, Inc., as commercial 

gauger and laboratory became effective 


dwashington3 on PROD1PC60 with NOTICES